CACHET PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.09 CNY | +0.54% |
|
+3.07% | -7.88% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 4,679 | 4,116 | 4,104 | 4,198 | 4,145 | 3,818 | - |
| Enterprise Value (EV) 1 | 4,679 | 4,116 | 4,104 | 4,198 | 4,145 | 3,818 | 3,818 |
| P/E ratio | 11.1 x | 12.9 x | - | - | - | - | - |
| Yield | 2.49% | - | 2.63% | 2.15% | 1.83% | 2.75% | 2.9% |
| Capitalization / Revenue | 0.21 x | - | 0.16 x | 0.16 x | 0.14 x | 0.13 x | 0.12 x |
| EV / Revenue | 0.21 x | - | 0.16 x | 0.16 x | 0.14 x | 0.13 x | 0.12 x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | 1.37 x | - | 1.06 x | 1.03 x | 0.98 x | 0.92 x | 0.91 x |
| Nbr of stocks (in thousands) | 291,707 | 291,707 | 291,707 | 291,707 | 291,707 | 291,707 | - |
| Reference price 2 | 16.04 | 14.11 | 14.07 | 14.39 | 14.21 | 13.09 | 13.09 |
| Announcement Date | 20-02-27 | 21-03-16 | 22-03-29 | 23-04-20 | 24-04-28 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 22,187 | - | 25,626 | 26,220 | 29,996 | 29,183 | 30,642 |
| EBITDA | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income | - | 317.6 | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - |
| EPS | 1.440 | 1.090 | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.4000 | - | 0.3700 | 0.3100 | 0.2600 | 0.3600 | 0.3800 |
| Announcement Date | 20-02-27 | 21-03-16 | 22-03-29 | 23-04-20 | 24-04-28 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 5,939 | 6,756 | 8,209 | 7,443 | 6,952 | 8,430 | 6,610 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
| Net income | 169.5 | 77.64 | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - |
| EPS | 0.5800 | 0.2700 | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-08-28 | 22-10-19 | 23-04-20 | 23-04-26 | 24-04-28 | 24-04-28 | - | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 13.4% | - | 11% | 7.49% | 6.03% | 7.5% | 8.4% |
| ROA (Net income/ Total Assets) | 3.12% | - | 4.19% | - | - | 1.8% | 1.9% |
| Assets | - | - | - | - | - | - | - |
| Book Value Per Share 1 | 11.70 | - | 13.30 | 14.00 | 14.50 | 14.20 | 14.30 |
| Cash Flow per Share 1 | 1.000 | - | 2.280 | -0.5600 | 5.470 | 0.8900 | 1.090 |
| Capex | - | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - | - |
| Announcement Date | 20-02-27 | 21-03-16 | 22-03-29 | 23-04-20 | 24-04-28 | - | - |
1CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
13.09
Average target price
-
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.88% | 526M | |
| -2.72% | 23.73B | |
| +3.91% | 8.28B | |
| +8.61% | 8.26B | |
| -18.57% | 8.07B | |
| +5.56% | 4.8B | |
| +19.12% | 4.26B | |
| -3.24% | 4.08B | |
| -1.86% | 3.92B | |
| +26.66% | 3.68B |
- Stock Market
- Equities
- 002462 Stock
- Financials Cachet Pharmaceutical Co., Ltd.